[S5] Symposium 5 Next-Generation Vaccine Development

10:10 〜 10:40

[S5-1] Modulating immunogenicity and reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization

○Yasuo Yoshioka^1,2,3,4,5 (1. Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan), 3. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 4. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 5. The Research Foundation for Microbial Diseases of Osaka University (Japan))

閲覧にはパスワードが必要です